Coupled Mixed Model for joint genetic analysis of complex disorders from independently collected data sets: application to Alzheimer's disease and substance use disorder
暂无分享,去创建一个
Eric P. Xing | Haohan Wang | Michael Vanyukov | M Liu | S Lee | W Wu | E. Xing | Haohan Wang | M. Vanyukov | W. Wu | S. Lee | M. Liu | M. Liu
[1] Ying Liu,et al. FaST linear mixed models for genome-wide association studies , 2011, Nature Methods.
[2] Eric P. Xing,et al. Precision Lasso: accounting for correlations and linear dependencies in high-dimensional genomic data , 2018, Bioinform..
[3] Eric P. Xing,et al. A time-varying group sparse additive model for genome-wide association studies of dynamic complex traits , 2016, Bioinform..
[4] Helen E. Gibson,et al. TRPV1 Channels Mediate Long-Term Depression at Synapses on Hippocampal Interneurons , 2008, Neuron.
[5] D. Boomsma,et al. GWIS: Genome-Wide Inferred Statistics for Functions of Multiple Phenotypes. , 2016, American journal of human genetics.
[6] S. Schneider,et al. Mutations in ANO3 cause dominant craniocervical dystonia: ion channel implicated in pathogenesis. , 2012, American journal of human genetics.
[7] Genetic risk for schizophrenia influences substance use in emerging adulthood: an event-level polygenic prediction model , 2017, bioRxiv.
[8] P. Visscher,et al. Simultaneous Discovery, Estimation and Prediction Analysis of Complex Traits Using a Bayesian Mixture Model , 2015, PLoS genetics.
[9] Joseph T. Glessner,et al. GWAS meta analysis identifies TSNARE1 as a novel Schizophrenia / Bipolar susceptibility locus , 2013, Scientific Reports.
[10] Bhupesh Sharma,et al. Protective effect of transient receptor potential vanilloid subtype 1 (TRPV1) modulator, against behavioral, biochemical and structural damage in experimental models of Alzheimer's disease , 2016, Brain Research.
[11] P. Lichtenstein,et al. Genome‐wide analysis of adolescent psychotic‐like experiences shows genetic overlap with psychiatric disorders , 2018, bioRxiv.
[12] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[13] M. Weiner,et al. Genomic Copy Number Analysis in Alzheimer's Disease and Mild Cognitive Impairment: An ADNI Study , 2011, International journal of Alzheimer's disease.
[14] David Heckerman,et al. FaST-LMM-Select for addressing confounding from spatial structure and rare variants , 2013, Nature Genetics.
[15] Eric P. Xing,et al. Multiplex Confounding Factor Correction for Genomic Association Mapping with Squared Sparse Linear Mixed Model , 2017, bioRxiv.
[16] Jian Huang,et al. LPG: A four-group probabilistic approach to leveraging pleiotropy in genome-wide association studies , 2018, BMC Genomics.
[17] Stephen P. Boyd,et al. Distributed Optimization and Statistical Learning via the Alternating Direction Method of Multipliers , 2011, Found. Trends Mach. Learn..
[18] J. Marchini,et al. A multiple phenotype imputation method for genetic studies , 2016, Nature Genetics.
[19] N. Chatterjee,et al. Heritability informed power optimization (HIPO) leads to enhanced detection of genetic associations across multiple traits , 2018, PLoS genetics.
[20] T. Yamauchi. Neuronal Ca2+/calmodulin-dependent protein kinase II--discovery, progress in a quarter of a century, and perspective: implication for learning and memory. , 2005, Biological & pharmaceutical bulletin.
[21] X. Wen,et al. Integrating molecular QTL data into genome-wide genetic association analysis: Probabilistic assessment of enrichment and colocalization , 2016, bioRxiv.
[22] K. Fromme,et al. Genetic risk for schizophrenia influences substance use in emerging adulthood: an event-level polygenic prediction model , 2017, bioRxiv.
[23] Gabriel E. Hoffman,et al. Correcting for Population Structure and Kinship Using the Linear Mixed Model: Theory and Extensions , 2013, PloS one.
[24] Naomi R. Wray,et al. Evidence of CNIH3 involvement in opioid dependence , 2015, Molecular Psychiatry.
[25] Zhiwu Zhang,et al. Mixed linear model approach adapted for genome-wide association studies , 2010, Nature Genetics.
[26] Y. Tsutsumi,et al. Proteomic analysis of the hippocampus in Alzheimer's disease model mice by using two-dimensional fluorescence difference in gel electrophoresis , 2013, Neuroscience Letters.
[27] Jong Wha J. Joo,et al. Meta-Analysis Identifies Gene-by-Environment Interactions as Demonstrated in a Study of 4,965 Mice , 2014, PLoS genetics.
[28] D. Tagle,et al. PACSIN 1 interacts with huntingtin and is absent from synaptic varicosities in presymptomatic Huntington's disease brains. , 2002, Human molecular genetics.
[29] M. Daly,et al. An Atlas of Genetic Correlations across Human Diseases and Traits , 2015, Nature Genetics.
[30] P. Visscher,et al. Advantages and pitfalls in the application of mixed-model association methods , 2014, Nature Genetics.
[31] P. Visscher,et al. MTAG: Multi-Trait Analysis of GWAS , 2017, bioRxiv.
[32] Marek Kimmel,et al. simuPOP: a forward-time population genetics simulation environment , 2005, Bioinform..
[33] Xiang Zhou,et al. Polygenic Modeling with Bayesian Sparse Linear Mixed Models , 2012, PLoS genetics.
[34] R. Huganir,et al. PICK1 interacts with PACSIN to regulate AMPA receptor internalization and cerebellar long-term depression , 2013, Proceedings of the National Academy of Sciences.
[35] Elizabeth M. Smigielski,et al. dbSNP: the NCBI database of genetic variation , 2001, Nucleic Acids Res..
[36] K. Roeder,et al. Genomic Control for Association Studies , 1999, Biometrics.
[37] Cun-Hui Zhang,et al. Adaptive Lasso for sparse high-dimensional regression models , 2008 .
[38] C. Wallace,et al. Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics , 2013, PLoS genetics.
[39] Eleazar Eskin,et al. Improved linear mixed models for genome-wide association studies , 2012, Nature Methods.
[40] Xiaofeng Zhu,et al. Meta-analysis of correlated traits via summary statistics from GWASs with an application in hypertension. , 2015, American journal of human genetics.
[41] Christoph Lange,et al. Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. , 2008, American journal of human genetics.
[42] Dan Geiger,et al. Multikernel linear mixed models for complex phenotype prediction , 2016, Genome research.
[43] A W Toga,et al. FASTKD2 is associated with memory and hippocampal structure in older adults , 2014, Molecular Psychiatry.
[44] R. Malenka,et al. Synaptic plasticity and addiction , 2007, Nature Reviews Neuroscience.
[45] Hongbing Shen,et al. Joint analysis of three genome- wide association studies of esophageal squamous cell carcinoma in Chinese populations , 2014 .
[46] J. Anthony,et al. Genome wide association for substance dependence: convergent results from epidemiologic and research volunteer samples , 2008, BMC Medical Genetics.
[47] Chang Liu,et al. Predicting Drug–Target Interactions Using Probabilistic Matrix Factorization , 2013, J. Chem. Inf. Model..
[48] S. Weiss,et al. Joint GWAS Analysis: Comparing similar GWAS at different genomic resolutions identifies novel pathway associations with six complex diseases , 2014, Genomics data.
[49] Xiang Zhou,et al. Pleiotropic Mapping and Annotation Selection in Genome-wide Association Studies with Penalized Gaussian Mixture Models , 2018, bioRxiv.
[50] A. J. Robison,et al. Emerging role of CaMKII in neuropsychiatric disease , 2014, Trends in Neurosciences.
[51] Jeesun Jung,et al. Epidemiology of DSM-5 Drug Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III. , 2016, JAMA psychiatry.
[52] H. Zou. The Adaptive Lasso and Its Oracle Properties , 2006 .
[53] P. Visscher,et al. 10 Years of GWAS Discovery: Biology, Function, and Translation. , 2017, American journal of human genetics.
[54] Eric P. Xing,et al. Variable selection in heterogeneous datasets: A truncated-rank sparse linear mixed model with applications to genome-wide association studies , 2017, BIBM.
[55] Valentin Dinu,et al. Data mining of high density genomic variant data for prediction of Alzheimer's disease risk , 2012, BMC Medical Genetics.
[56] Mary A. Logan,et al. Glial Draper Rescues Aβ Toxicity in a Drosophila Model of Alzheimer's Disease , 2017, The Journal of Neuroscience.
[57] Vidar M. Steen,et al. The Complement Control-Related Genes CSMD1 and CSMD2 Associate to Schizophrenia , 2011, Biological Psychiatry.
[58] Trevor J. Hastie,et al. Genome-wide association analysis by lasso penalized logistic regression , 2009, Bioinform..
[59] Stephen P. Boyd,et al. Proximal Algorithms , 2013, Found. Trends Optim..
[60] Peggy Hall,et al. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations , 2013, Nucleic Acids Res..
[61] R. Harris,et al. Deletion of vanilloid receptor (TRPV1) in mice alters behavioral effects of ethanol , 2009, Neuropharmacology.
[62] Wei Liu,et al. Joint modeling of genetically correlated diseases and functional annotations increases accuracy of polygenic risk prediction , 2017, PLoS genetics.
[63] Y. Sunada,et al. A simplified and sensitive method to identify Alzheimer's disease biomarker candidates using patient-derived induced pluripotent stem cells (iPSCs). , 2017, Journal of biochemistry.
[64] Hyoung‐Chun Kim,et al. Transient Receptor Potential Vanilloid Type 1 Channel May Modulate Opioid Reward , 2014, Neuropsychopharmacology.
[65] R. Huganir,et al. Disruption of Glutamate Receptor-Interacting Protein in Nucleus Accumbens Enhances Vulnerability to Cocaine Relapse , 2014, Neuropsychopharmacology.
[66] David W. Self,et al. Striatal Signal Transduction and Drug Addiction , 2011, Front. Neuroanat..
[67] R. Crystal,et al. Cigarette smoking induces small airway epithelial epigenetic changes with corresponding modulation of gene expression , 2013, Epigenetics & Chromatin.
[68] B. Grant,et al. Epidemiology of DSM-5 Alcohol Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions III. , 2015, JAMA psychiatry.
[69] H. Kang,et al. Variance component model to account for sample structure in genome-wide association studies , 2010, Nature Genetics.
[70] P. Visscher,et al. Multi-trait analysis of genome-wide association summary statistics using MTAG , 2017, Nature Genetics.
[71] O L Lopez,et al. Genome-wide copy-number variation study of psychosis in Alzheimer's disease , 2015, Translational Psychiatry.
[72] Y. Bae,et al. MEGF10 functions as a receptor for the uptake of amyloid‐β , 2010, FEBS letters.
[73] Eleazar Eskin,et al. Imputing Phenotypes for Genome-wide Association Studies. , 2016, American journal of human genetics.
[74] Chao Yang,et al. LLR: a latent low‐rank approach to colocalizing genetic risk variants in multiple GWAS , 2017, Bioinform..
[75] Robert D Gibbons,et al. Multiple imputation for harmonizing longitudinal non‐commensurate measures in individual participant data meta‐analysis , 2015, Statistics in medicine.
[76] Bonnie Berger,et al. Improving the Power of GWAS and Avoiding Confounding from Population Stratification with PC-Select , 2014, Genetics.
[77] M. Karimi,et al. The Role of Dopamine and Dopaminergic Pathways in Dystonia: Insights from Neuroimaging , 2015, Tremor and other hyperkinetic movements.
[78] Doug Speed,et al. MultiBLUP: improved SNP-based prediction for complex traits , 2014, Genome research.
[79] C. Langefeld,et al. Genome-Wide Association Scan for Survival on Dialysis in African-Americans with Type 2 Diabetes , 2011, American Journal of Nephrology.
[80] Anders D. Børglum,et al. Genome-wide association study identifies five new schizophrenia loci , 2011, Nature Genetics.
[81] Tom R. Gaunt,et al. DNA methylation and substance-use risk: a prospective, genome-wide study spanning gestation to adolescence , 2016, Translational psychiatry.
[82] D. Rujescu,et al. Trans-ancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders , 2018, Nature Neuroscience.
[83] J. Kornhuber,et al. CaM Kinases: From Memories to Addiction. , 2016, Trends in pharmacological sciences.
[84] Sungeun Kim,et al. GWAS of the joint ADGC data set identifies novel common variants associated with late-onset Alzheimer's disease , 2013, Alzheimer's & Dementia.